News

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
MHRA launches genetic study into GLP-1 drug risks as Spain investigates Novo Nordisk for potential advertising violations.
Novo Nordisk has launched its weight-loss drug Wegovy in India, while Eli Lilly's Mounjaro has received regulatory approval, ...
Without these two documents, your weight-loss medication could get confiscated or you could be held by the authorities if you ...
You've heard about the likes of Ozempic, Wegovy and Mounjaro, jabs which a growing number of people are taking in an attempt ...
‘What The Fat?’, co-authored by Caryn Zinn, Craig Rodger, and Grant Schofield, highlights a low-carb, healthy-fat diet, and is held up as an effective weight loss tool. Dr Zinn joined Kerre Woodham ...
Going on holiday with weight-loss jabs could land you in a lot of trouble as they are banned or regulated in some countries ...
A growing number of Americans are trying popular weight-loss drugs touted by celebrities, health care providers and others. Should you?
Serious concerns have emerged about falsified weight loss medicines circulating in the UK market, posing significant health ...
There have been hundreds of cases of acute pancreatitis in people who have also taken Mounjaro, Ozempic and Wegovy.
Health officials launch fresh study into their side effects after reported cases of pancreatitis, some of which were fatal ...